SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is generating intense buzz ahead of its highly anticipated BlueBird 6 satellite launch, which is viewed as a pivotal moment for its space-based cellular network deployment. The community is sharply divided, with fervent bulls anticipating substantial gains post-launch, while bears warn of an overvalued stock and a potential "sell the news" event. This dichotomy is fueling significant conversation and market volatility around the company's future in satellite communications.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending due to anticipation surrounding its showcase of commercial quantum computing solutions and real-world applications at an upcoming major tech event, fueling speculation about its "quantum supremacy" in optimization. The community is actively debating its potential as a generational technology, drawing comparisons to early AI, while skeptics point to its current low revenue, cash burn, and perceived overvaluation amidst allegations of manipulated "pump and dump" cycles.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending due to widespread anticipation surrounding the outcome of a recent FDA meeting concerning its lead drug, Sonelokimab, for Hidradenitis Suppurativa. The community largely expects a positive regulatory update, which many believe would significantly de-risk the asset. This has intensified discussions about a potential acquisition by a major pharmaceutical player, fueled by reported prior interest and recent executive share conversions interpreted by some as preparatory for a substantial transaction.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X (CCCX) is trending amid strong community buzz surrounding its upcoming merger with Infleqtion, a quantum technology leader. Investors are highlighting Infleqtion's established partnerships with defense and aerospace entities, along with its commercially viable quantum sensing and timing solutions, which many believe are significantly undervalued compared to sector peers. The sentiment suggests anticipation for substantial institutional investment and accelerated growth once the ticker changes post-merger.

Starfighters Space Inc

Starfighters Space Inc. (FJET) is experiencing extreme volatility following its recent IPO, igniting intense community debate. Bulls highlight its low float and aerospace sector exposure as potential catalysts for a massive squeeze, while skeptics label it a pump-and-dump, raising concerns about its valuation, pre-revenue status, and the qualifications of its R&D team. The stock's dramatic price swings and unusually high short borrow fees are central to the ongoing, heated discussion.

TOSHI

TOSHI is a trending topic, with its community deeply engaged in discussions around its role as the "Face of Base" blockchain following recent listings on major exchanges and a Coinbase One collaboration. Despite recent market volatility, the "blue cat" faithful are actively accumulating, anticipating future growth and potential listings on platforms like Robinhood or Binance, highlighting strong long-term conviction.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore Corp. is trending after receiving federal regulatory approval to restart its Las Flores Pipeline System, a move perceived as a crucial step toward reactivating its California offshore oil assets under federal oversight. This development has spurred significant community discussion, with many investors anticipating substantial upside and a potential short squeeze, while others remain cautious due to the company's financial concerns and the likelihood of continued state-level legal and permitting challenges.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending with intense anticipation surrounding a pivotal FDA decision for its drug Narsoplimab (Yartemlea) by December 26th, targeting a life-threatening condition without an approved treatment. This binary event is bolstered by the recent closing of a significant deal with Novo Nordisk, bringing in substantial upfront cash and potential future milestones, along with a $100 million share repurchase program, fueling community expectations for a transformative approval and a notable short squeeze.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust (SLV) is seeing intense bullish momentum, with spot silver prices reaching new all-time highs, driven by tightening global supply due to upcoming Chinese export restrictions and surging industrial demand from sectors like EVs, solar, and AI data centers. The community is actively discussing a potential 'silver squeeze' and a significant re-rating of silver's value, though some anticipate a near-term pullback after its rapid ascent.

Ascent Solar Technologies, Inc. engages in the design, development, and manufacture of solar technology and power solutions for remote locations and extreme environments. It integrates photovoltaic modules into a variety of applications such as aerospace, defense, transportation, and electronic products. The company was founded by Mohan S. Misra and Joseph H. Armstrong on October 18, 2005 and is headquartered in Thornton, CO.

Ascent Solar Technologies Inc

Ascent Solar Technologies is generating buzz following a series of strategic teaming agreements that position its specialized thin-film solar technology for critical applications across the growing space, aerospace, and defense sectors. The community is actively debating the stock's high volatility and long-term potential for significant contracts, with discussions weighing its innovative solar solutions for lunar missions and drone powering against concerns about its historical dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's What You Should Know

CAMP4 Therapeutics Corporation (CAMP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

Current Price	$5.94
Prev Close	$6.00
Open	$5.94
Dividend Yield	0.00%
50-Day Moving Average	$4.24
Beta	1.43
Avg. Volume	91,831.05
PE Ratio	-2.42

52-Week High	$7.31
52-Week Low	$1.31
Market Capitalization	$311.29M
EPS (Annual)	-$2.57
Price to Book	4.75
Revenue Per Employee	$11,854.55
Enterprise Value/EBITDA	N/A

CAMP
Calamp Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CAMP News

CAMPCalamp Corp.